Methods: Tumor microarrays of pancreatic ductal adenocarcinoma (PDAC) were used to evaluate the clinicopathological variables and GSTM3 expression by immunohistochemical staining. This evidence concerns the gene GSTM3 and pancreatic ductal adenocarcinoma.